SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-283883
Filing Date
2015-08-10
Accepted
2015-08-10 07:35:57
Documents
4
Period of Report
2015-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d62044d8k.htm 8-K 14212
2 EX-99.1 d62044dex991.htm EX-99.1 77878
3 GRAPHIC g62044ex99_1pg001a.jpg GRAPHIC 12094
4 GRAPHIC g62044ex99_1pg001b.jpg GRAPHIC 4229
  Complete submission text file 0001193125-15-283883.txt   115994
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 151039197
SIC: 2834 Pharmaceutical Preparations